Education
About Us
Working with TipRanks
Follow Us
Soligenix Inc (SNGX)
NASDAQ:SNGX
SNGX Stock Chart & Stats
$1.23
-$0.10(-2.65%)
At close: 4:00 PM EST
$1.23
-$0.10(-2.65%)
Day’s Range― - ―
52-Week Range$1.09 - $6.23
Previous CloseN/A
Volume55.16K
Average Volume (3M)377.67K
Market Cap
$13.92M
Enterprise Value-$5.12M
Total Cash (Recent Filing)$5.10M
Total Debt (Recent Filing)$411.40K
Price to Earnings (P/E)―
Beta0.28
Next Earnings
Mar 31, 2026EPS Estimate
-0.56Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.58
Shares Outstanding10,086,130
10 Day Avg. Volume600,362
30 Day Avg. Volume377,672
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.09
Price to Sales (P/S)37.55
P/FCF Ratio-0.53
Enterprise Value/Market Cap-0.37
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.28K
Enterprise Value/Ebitda0.44
Forecast
1Y Price Target
$10.00Price Target Upside713.01% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-2.6
Revenue Forecast (FY)$800.00K
Soligenix News
SNGX FAQ
What was Soligenix Inc’s price range in the past 12 months?
Soligenix Inc lowest stock price was $1.09 and its highest was $6.23 in the past 12 months.
What is Soligenix Inc’s market cap?
Soligenix Inc’s market cap is $13.92M.
When is Soligenix Inc’s upcoming earnings report date?
Soligenix Inc’s upcoming earnings report date is Mar 31, 2026 which is in 97 days.
How were Soligenix Inc’s earnings last quarter?
Soligenix Inc released its earnings results on Nov 07, 2025. The company reported -$0.58 earnings per share for the quarter, missing the consensus estimate of -$0.555 by -$0.025.
Is Soligenix Inc overvalued?
According to Wall Street analysts Soligenix Inc’s price is currently Undervalued.
Does Soligenix Inc pay dividends?
Soligenix Inc does not currently pay dividends.
What is Soligenix Inc’s EPS estimate?
Soligenix Inc’s EPS estimate is -0.56.
How many shares outstanding does Soligenix Inc have?
Soligenix Inc has 10,086,130 shares outstanding.
What happened to Soligenix Inc’s price movement after its last earnings report?
Soligenix Inc reported an EPS of -$0.58 in its last earnings report, missing expectations of -$0.555. Following the earnings report the stock price went up 7.031%.
Which hedge fund is a major shareholder of Soligenix Inc?
Currently, no hedge funds are holding shares in SNGX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Soligenix Inc
Soligenix, Inc. (SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company's core sectors include biotherapeutics and public health solutions. Within biotherapeutics, it is engaged in the development of specialized drug products for oncology, inflammation, and biodefense. Soligenix's lead product candidates include SGX301, a novel photodynamic therapy for cutaneous T-cell lymphoma, and SGX942, an innate defense regulator for the treatment of oral mucositis in head and neck cancer patients.
SNGX Stock 12 Month Forecast
Average Price Target
$10.00
▲(713.01% Upside)
Technical Analysis
Bioline RX Ltd Sponsored ADR
―
Can-Fite BioPharma
―
GeoVax Labs
―
Ainos
―
Athira Pharma
―
Ownership Overview
3.86% Insiders
0.57% Mutual Funds
10.49% Other Institutional Investors
84.77% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---